Eric Meurice - 02 Feb 2026 Form 4 Insider Report for IPG PHOTONICS CORP (IPGP)

Role
Director
Signature
/s/ Adam N. King, Attorney-in-Fact
Issuer symbol
IPGP
Transactions as of
02 Feb 2026
Net transactions value
-$5,348
Form type
4
Filing time
03 Feb 2026, 16:30:19 UTC
Previous filing
07 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Meurice Eric Director C/O IPG PHOTONICS CORPORATION, 377 SIMARANO DRIVE, MARLBOROUGH /s/ Adam N. King, Attorney-in-Fact 03 Feb 2026 0001372258

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IPGP Common Stock Options Exercise $65,902 +750 +3.3% $87.87 23,553 02 Feb 2026 Direct
transaction IPGP Common Stock Sale $71,250 -750 -3.2% $95.00 22,803 02 Feb 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IPGP Director Stock Option (right to buy) Options Exercise $0 -750 -100% $0.000000 0 02 Feb 2026 Common Stock 750 $87.87 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2025.
F2 Grant of stock options vesting 100% on earlier of 6/1/2017 or date of 2017 annual stockholder meeting of Issuer.